Saturday, June 07, 2025 | 09:43 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Moderna's Omicron-adapted Covid vaccine wins first approval in Britain

The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by the US drug company Moderna as a booster for adults

Moderna
premium

Illustration: Reuters

Reuters
Britain has become the first country to approve a COVID-19 vaccine that targets both the original and Omicron variant of the virus.

The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna as a booster for adults.

The agency's decision was based on clinical trial data that showed the booster triggered "a strong immune response" against both Omicron (BA.1) and the original 2020 virus, it said.

The MHRA also cited an exploratory analysis in which the shot was found to generate a good immune response against the currently dominant Omicron offshoots BA.4 and BA.5.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)